Theravance Biopharma, Inc. (TBPH) - Stock Prices, Stock Peers & Analysis

Home
TBPH

Company Name	Theravance Biopharma, Inc.
Symbol	TBPH
Currency	USD
Price	8.01
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	391,866,021
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	7.44 - 11.71
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Rick E. Winningham M.B.A.
Website	https://www.theravance.com

An error occurred while fetching data.

About Theravance Biopharma, Inc.

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK)